SCHEMBL8026593

SCHEMBL8026593

COc1c(Cl)ccc2c(NC(C)=O)cccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ IDO1 P14902 1/20 0.51
▸ PARP14 Q460N5 1/20 0.48
▸ TAS1R3 Q7RTX0 2/20 0.46
▸ TAS1R1 Q7RTX1 2/20 0.46
▸ TAS1R2 Q8TE23 2/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ HPGD P15428 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ BRAF P15056 1/20 0.43
▸ TRPV1 Q8NER1 1/20 0.42
▸ CASP6 P55212 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.41
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351442 0.80 PARP14 (0.54) KDM4EPARP14ALDH1A1KMT2AMEN1
SCHEMBL31570817 0.79 RXFP1 (0.54) KDM4ECYP1A2PARP14ALDH1A1KMT2A
SCHEMBL3182003 0.79 RXFP1 (0.54) KDM4ECYP1A2PARP14ALDH1A1KMT2A
SCHEMBL1900214 0.79 RXFP1 (0.66) KDM4EPARP14ALDH1A1KMT2AMEN1
SCHEMBL11587318 0.77 TAS1R3 (0.37) KDM4ETAS1R3TAS1R1TAS1R2ALDH1A1
SCHEMBL8029704 0.76 KMT2A (0.55) KDM4EALDH1A1KMT2AMEN1RXFP1
SCHEMBL14444101 0.76 RXFP1 (0.64) KDM4ECYP1A2PARP14ALDH1A1KMT2A
SCHEMBL18814229 0.76 RXFP1 (0.54) KDM4EALDH1A1KMT2AMEN1RXFP1
SCHEMBL9815076 0.76 KDM4E (0.58) KDM4ECYP1A2CYP2C9IDO1PARP14
SCHEMBL8054306 0.74 CA1 (0.49) KDM4EPARP14ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603954-B1 Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer JOHNSON & JOHNSON CLIN DIAG (US) 2000-03-08 — — EP disclosed
EP-0603953-B1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods JOHNSON & JOHNSON CLIN DIAG (US) 1999-02-17 — — EP disclosed
US-5736335-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1998-04-07 — — US disclosed
US-5641635-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1997-06-24 — — US disclosed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 — — US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 — — US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 — — EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 — — EP disclosed
Send feedback